tetano
Editor, Senior Moderator
BMC Musculoskelet Disord
. 2023 Dec 6;24(1):949.
doi: 10.1186/s12891-023-07062-w. Femoral nerve palsy as a complication due to COVID-19 coagulopathy and iliopsoas muscle hematoma - case report
Sławomir Tutak[SUP] 1 [/SUP], Paweł Bartosz[SUP] 2 [/SUP], Bartosz Burda[SUP] 1 [/SUP], Paweł Sztwiertnia[SUP] 3 [/SUP], Jerzy Białecki[SUP] 1 [/SUP]
Affiliations
Background: COVID-19 (Coronavirus disease 2019) pandemic is the main medical problem around the world from the end of 2019. We found until now many symptoms of this disease, but one of the most problematic was thrombosis. Wide recommendation on COVID-19 treatment was pharmacological thromboprophylaxis. In some papers we found that clinicians face the problem of bleeding in those patients. Is still unknown that coronavirus could led to the coagulopathy.
Case presentation: We described case report of patient who with COVID-19 disease present femoral nerve palsy caused by the iliopsoas hematoma. There were no deviations in coaguology parameters, patient got standard thromboprophylaxis, besides above probably COVID-19 was risk factor of hematoma formation. Non-operative treatment was applied, thrombophylaxis was discontinued. In the follow up in the radiological exam we saw reduction of the haematoma and patient report decrease of symptoms.
Conclusions: We should assess individually patient with COVID-19 according to thrombosis risk factors. Probably we should be more careful in ordering thrombophylaxis medications in COVID-19 patients.
Keywords: COVID-19; Coagulopathy; Hematoma; Nerve; Paresis.
. 2023 Dec 6;24(1):949.
doi: 10.1186/s12891-023-07062-w. Femoral nerve palsy as a complication due to COVID-19 coagulopathy and iliopsoas muscle hematoma - case report
Sławomir Tutak[SUP] 1 [/SUP], Paweł Bartosz[SUP] 2 [/SUP], Bartosz Burda[SUP] 1 [/SUP], Paweł Sztwiertnia[SUP] 3 [/SUP], Jerzy Białecki[SUP] 1 [/SUP]
Affiliations
- PMID: 38057812
- DOI: 10.1186/s12891-023-07062-w
Background: COVID-19 (Coronavirus disease 2019) pandemic is the main medical problem around the world from the end of 2019. We found until now many symptoms of this disease, but one of the most problematic was thrombosis. Wide recommendation on COVID-19 treatment was pharmacological thromboprophylaxis. In some papers we found that clinicians face the problem of bleeding in those patients. Is still unknown that coronavirus could led to the coagulopathy.
Case presentation: We described case report of patient who with COVID-19 disease present femoral nerve palsy caused by the iliopsoas hematoma. There were no deviations in coaguology parameters, patient got standard thromboprophylaxis, besides above probably COVID-19 was risk factor of hematoma formation. Non-operative treatment was applied, thrombophylaxis was discontinued. In the follow up in the radiological exam we saw reduction of the haematoma and patient report decrease of symptoms.
Conclusions: We should assess individually patient with COVID-19 according to thrombosis risk factors. Probably we should be more careful in ordering thrombophylaxis medications in COVID-19 patients.
Keywords: COVID-19; Coagulopathy; Hematoma; Nerve; Paresis.